Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-24 6:47 pm Sale |
2025-03-24 | 13G | Evoke Pharma, Inc. EVOK |
Bleichroeder LP | 158,058 9.990% |
-691,309 (-81.39%) |
Filing History |
| 2025-03-21 7:15 pm Purchase |
2025-03-19 | 13G | Evoke Pharma, Inc. EVOK |
Bleichroeder LP | 849,367 9.990% |
778,586 (+1100.00%) |
Filing History |
| 2025-02-03 4:47 pm Purchase |
2025-02-03 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 254,639 15.990% |
7 (+0.00%) |
Filing History |
| 2024-11-14 1:08 pm Purchase |
2024-09-30 | 13G | Evoke Pharma, Inc. EVOK |
LYTTON LAURENCE W | 74,757 9.990% |
74,757 (New Position) |
Filing History |
| 2024-11-14 09:19 am Purchase |
2024-09-30 | 13G | Evoke Pharma, Inc. EVOK |
Altium Capital Management LLC | 153,186 4.990% |
153,186 (New Position) |
Filing History |
| 2024-11-06 4:31 pm Purchase |
2024-11-06 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 254,632 15.990% |
169,946 (+200.68%) |
Filing History |
| 2024-10-29 7:47 pm Unchanged |
2024-10-29 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-01 4:53 pm Unchanged |
2024-09-27 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 84,686 10.000% |
0 (Unchanged) |
Filing History |
| 2024-09-20 7:28 pm Purchase |
2024-09-20 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 84,686 10.000% |
84,686 (New Position) |
Filing History |
| 2024-03-13 1:32 pm Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
LYTTON LAURENCE W | 71,610 9.990% |
71,610 (New Position) |
Filing History |
| 2024-03-11 6:39 pm Purchase |
2024-02-13 | 13G | Evoke Pharma, Inc. EVOK |
Bleichroeder LP | 70,781 9.990% |
70,781 (New Position) |
Filing History |
| 2024-02-20 4:38 pm Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
Altium Capital Management LLC | 153,186 9.700% |
153,186 (New Position) |
Filing History |
| 2024-02-13 06:34 am Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 70,583 9.990% |
70,583 (New Position) |
Filing History |
| 2021-05-06 4:20 pm Purchase |
2021-04-30 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 11,814 5.300% |
1,862 (+18.71%) |
Filing History |
| 2021-03-25 6:28 pm Sale |
2021-03-19 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 9,952 4.400% |
-1,853 (-15.70%) |
Filing History |
| 2021-01-20 07:20 am Purchase |
2021-01-14 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 11,806 5.300% |
11,806 (New Position) |
Filing History |